OBJECTIVE: Several chronic diseases have been hypothesized to affect the risk of subsequent gynecologic malignancies, possibly through shared hormonal mechanisms. METHODS: Using record linkage techniques, we assessed the relationships between hospital and outpatient admissions for gallbladder disease, diabetes, hypertension, thyroid diseases and obesity and the subsequent development of uterine and ovarian cancers in Denmark between 1978 and 1998. Based on a subsample of more than 99,000 women, including 1398 uterine and 2491 ovarian cancers, we derived relative risks (RRs) and 95% confidence intervals (CIs) associated with overall and histology-specific cancer risks after adjustment for age, calendar time and reproductive characteristics. RESULTS: Uterine cancers were related to previous diagnoses of thyroid diseases (RR=1.52, 95% CI 1.17-1.98) and obesity (2.05, 1.40-3.00). Associations with diabetes were confounded by obesity, but there were some elevations in risk for subjects diagnosed with obesity prior to age 45 (RRs 1.66-1.79). Although the "usual types" of endometrial cancer largely accounted for the observed associations, there was some evidence that uterine sarcomas (n=137) were related to prior diagnoses of thyroid diseases (2.78, 1.41-5.50). In contrast, ovarian cancers were not strongly related to most documented chronic diseases. Serous carcinomas were associated with gallbladder diseases of short durations, but detection bias or misdiagnosis probably accounts for this association. An association of obesity and endometrioid ovarian cancer was not identified. CONCLUSIONS: Uterine cancers, including sarcomas, appear to be influenced by selected chronic diseases. Further attention should focus on possible biologic mechanisms underlying observed associations with thyroid diseases and obesity.
OBJECTIVE: Several chronic diseases have been hypothesized to affect the risk of subsequent gynecologic malignancies, possibly through shared hormonal mechanisms. METHODS: Using record linkage techniques, we assessed the relationships between hospital and outpatient admissions for gallbladder disease, diabetes, hypertension, thyroid diseases and obesity and the subsequent development of uterine and ovarian cancers in Denmark between 1978 and 1998. Based on a subsample of more than 99,000 women, including 1398 uterine and 2491 ovarian cancers, we derived relative risks (RRs) and 95% confidence intervals (CIs) associated with overall and histology-specific cancer risks after adjustment for age, calendar time and reproductive characteristics. RESULTS: Uterine cancers were related to previous diagnoses of thyroid diseases (RR=1.52, 95% CI 1.17-1.98) and obesity (2.05, 1.40-3.00). Associations with diabetes were confounded by obesity, but there were some elevations in risk for subjects diagnosed with obesity prior to age 45 (RRs 1.66-1.79). Although the "usual types" of endometrial cancer largely accounted for the observed associations, there was some evidence that uterine sarcomas (n=137) were related to prior diagnoses of thyroid diseases (2.78, 1.41-5.50). In contrast, ovarian cancers were not strongly related to most documented chronic diseases. Serous carcinomas were associated with gallbladder diseases of short durations, but detection bias or misdiagnosis probably accounts for this association. An association of obesity and endometrioid ovarian cancer was not identified. CONCLUSIONS: Uterine cancers, including sarcomas, appear to be influenced by selected chronic diseases. Further attention should focus on possible biologic mechanisms underlying observed associations with thyroid diseases and obesity.
Authors: S H Olson; M Trevisan; J R Marshall; S Graham; M Zielezny; J E Vena; R Hellmann; J L Freudenheim Journal: Nutr Cancer Date: 1995 Impact factor: 2.900
Authors: G S Boyer; D W Templin; W P Goring; J C Cornoni-Huntley; D F Everett; R C Lawrence; S P Heyse; A Bowler Journal: Arch Intern Med Date: 1995-09-25
Authors: Kathleen M Fairfield; Walter C Willett; Bernard A Rosner; JoAnn E Manson; Frank E Speizer; Susan E Hankinson Journal: Obstet Gynecol Date: 2002-08 Impact factor: 7.661
Authors: S M Schwartz; N S Weiss; J R Daling; M D Gammon; J M Liff; J Watt; C F Lynch; P A Newcomb; B K Armstrong; W D Thompson Journal: Cancer Date: 1996-02-15 Impact factor: 6.860
Authors: Christine Friedenreich; Anne Cust; Petra H Lahmann; Karen Steindorf; Marie-Christine Boutron-Ruault; Françoise Clavel-Chapelon; Sylvie Mesrine; Jakob Linseisen; Sabine Rohrmann; Tobias Pischon; Mandy Schulz; Anne Tjønneland; Nina Fons Johnsen; Kim Overvad; Michelle Mendez; M V Arguelles; Carmen Martinez Garcia; Nerea Larrañaga; María-Dolores Chirlaque; Eva Ardanaz; Sheila Bingham; Kay-Tee Khaw; Naomi Allen; Tim Key; Antonia Trichopoulou; Vardis Dilis; Dimitrios Trichopoulos; Valeria Pala; Domenico Palli; Rosario Tumino; Salvatore Panico; Paolo Vineis; H Bas Bueno-de-Mesquita; Petra H M Peeters; Evelyn Monninkhof; Göran Berglund; Jonas Manjer; Nadia Slimani; Pietro Ferrari; Rudolf Kaaks; Elio Riboli Journal: Int J Cancer Date: 2007-07-15 Impact factor: 7.396
Authors: L D Kellenberger; J E Bruin; J Greenaway; N E Campbell; R A Moorehead; A C Holloway; J Petrik Journal: J Oncol Date: 2010-02-17 Impact factor: 4.375
Authors: E Shinderman-Maman; K Cohen; C Weingarten; D Nabriski; O Twito; L Baraf; A Hercbergs; P J Davis; H Werner; M Ellis; O Ashur-Fabian Journal: Oncogene Date: 2015-07-13 Impact factor: 9.867
Authors: Diana J Moke; Ann S Hamilton; Leena Chehab; Dennis Deapen; David R Freyer Journal: Cancer Epidemiol Biomarkers Prev Date: 2019-07-23 Impact factor: 4.254
Authors: Neige M Y Journy; Marie-Odile Bernier; Michele M Doody; Bruce H Alexander; Martha S Linet; Cari M Kitahara Journal: Thyroid Date: 2017-07-06 Impact factor: 6.568
Authors: Joan Fortuny; Camelia Sima; Sharon Bayuga; Homer Wilcox; Katherine Pulick; Shameka Faulkner; Ann G Zauber; Sara H Olson Journal: Cancer Epidemiol Biomarkers Prev Date: 2009-04-21 Impact factor: 4.254
Authors: Michael F Leitzmann; Corinna Koebnick; Kim N Danforth; Louise A Brinton; Steven C Moore; Albert R Hollenbeck; Arthur Schatzkin; James V Lacey Journal: Cancer Date: 2009-02-15 Impact factor: 6.860